ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,564.41
      1.08%
      US Tech 100
      19,282.40
      1.44%
      Dow Jones
      40,421.36
      0.33%
      Brent Oil
      81.575
      -0.86%
      Bitcoin
      67,970.95
      -0.27%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Vor Biopharma Inc (VOR) Quote

      Vor Biopharma Inc

      Vor Biopharma Inc (VOR)

      Vortiv Limited
      0.925
      0.0017
      (0.18%)
      At close: July 22 4:00PM
      Delayed by 15 minutes
      0.925
      0.00
      ( 0.00% )
      After Hours: 4:30PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      0.925
      Bid
      0.9072
      Ask
      0.9699
      Volume
      123,348
      0.9161 Day's Range 0.96
      0.90 52 Week Range 3.38
      Market Cap
      63.024M
      Previous Close
      0.9233
      Open
      0.9161
      Last Trade
      5267
      @
      0.925
      (priorref)
      Last Trade Time
      16:22:24
      Financial Volume
      $ 115,330
      VWAP
      0.934999
      Average Volume (3m)
      297,247
      Shares Outstanding
      68,259,602
      Dividend Yield
      -
      PE Ratio
      -0.53
      Earnings Per Share (EPS)
      -1.73
      Revenue
      -
      Net Profit
      -117.86M

      About Vor Biopharma Inc

      Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33. Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.vorbio.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      1970
      Vor Biopharma Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker VOR. The last closing price for Vor Biopharma was $0.92. Over the last year, Vor Biopharma shares have traded in a share price range of $ 0.90 to $ 3.38.

      Vor Biopharma currently has 68,259,602 shares outstanding. The market capitalization of Vor Biopharma is $63.02 million. Vor Biopharma has a price to earnings ratio (PE ratio) of -0.53.

      VOR Latest News

      More News

      Form 144 - Report of proposed sale of securities

      July 19 2024
      Edgar (US Regulatory)

      Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

      CAMBRIDGE, Mass., July 09, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, effective as of July 1, 2024, the...

      July 09 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      June 10 2024
      Edgar (US Regulatory)

      Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

      CAMBRIDGE, Mass., June 04, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, effective as of June 1, 2024, the...

      June 04 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      May 28 2024
      Edgar (US Regulatory)

      Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update

      On-track for trem-cel and VCAR33ALLO clinical updates in the second half of 2024Trem-cel trial expanded to include patients with myelodysplastic syndromes (MDS); Mylotarg™ dosing has advanced to...

      May 09 2024
      GlobeNewswire Inc.

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      May 09 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      May 07 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      May 07 2024
      Edgar (US Regulatory)

      Vor Bio to Participate in Upcoming Investor Conferences

      CAMBRIDGE, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming...

      May 06 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.055-5.612244897960.981.10.9083357760.96170744CS
      4-0.255-21.61016949151.181.270.93264861.01733035CS
      12-0.805-46.53179190751.731.870.92972471.33677248CS
      26-1.375-59.78260869572.32.50.93035761.74091402CS
      52-2.405-72.22222222223.333.380.92125991.89474782CS
      156-13.975-93.791946308714.918.5150.91631224.94208253CS
      260-41.095-97.798667301342.0263.620.91683279.63834332CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AAGRAfrican Agriculture Holdings Inc
      $ 0.00
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 0.00
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 0.00
      (0.00%)
      		0
      AACIArmada Acquisition Corporation I
      $ 0.00
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.00
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.00
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 0.00
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 0.00
      (0.00%)
      		0
      AACIArmada Acquisition Corporation I
      $ 0.00
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.00
      (0.00%)
      		0
      NVDANVIDIA Corporation
      $ 123.39
      (-0.28%)
      		22.4M
      LIFWMSP Recovery Inc
      $ 0.8501
      (70.46%)
      		5.31M
      MIRAMIRA Pharmaceuticals Inc
      $ 3.94
      (-21.36%)
      		4.18M
      HRTXHeron Therapeautics Inc
      $ 3.20
      (0.00%)
      		3.01M
      LUXHLuxUrban Hotels Inc
      $ 0.169
      (14.73%)
      		2.32M

      VOR Discussion

      View Posts
      Monksdream Monksdream 3 weeks ago
      VOR new 52 week low
      👍️0
      Monksdream Monksdream 3 weeks ago
      VOR new 52 week low
      👍️0
      PonkenPlonken PonkenPlonken 3 weeks ago
      Sid Mukherjee saw the potential in Saar Gills and Carl Junes approach and funded VOR==== shielding the right cells and attacking the cancer. For simplicity, it could be summed up as bottom up selectivity.................
      Very different from all the other CAR T stuff out there that is pretty much top-down-y. And in my opinion, top down systems dont work.
      5am and RA certainly think so. Will go back to the IPO price and then some is my bet.
      👍️0
      Monksdream Monksdream 3 weeks ago
      GNPX new 52 week low

      👍️0
      PonkenPlonken PonkenPlonken 3 weeks ago
      Im starting to think someone just buys them out.
      Interesting action yesterday.
      👍️0
      Monksdream Monksdream 2 months ago
      VOR new 52 week low
      👍️0
      Monksdream Monksdream 2 months ago
      VOR new 52 week low
      👍️0
      PonkenPlonken PonkenPlonken 2 months ago
      elevated volume for quite some time now.
      👍️0
      PonkenPlonken PonkenPlonken 3 months ago
      https://en.wikipedia.org/wiki/Siddhartha_Mukherjee founder is a smart man. They can do Car T without the tox.
      👍️0
      Monksdream Monksdream 4 months ago
      VORBunder $2
      👍️0
      glenn1919 glenn1919 4 months ago
      VOR.....................................https://stockcharts.com/h-sc/ui?s=VOR&p=W&b=5&g=0&id=p86431144783
      👍️0

      Your Recent History

      NASDAQ
      VOR
      Vor Biopharma
      Delayed Upgrade Clock